相似文献
1
Clinical and virologic response to episodic acyclovir for genital ulcers among HIV-1 seronegative, herpes simplex virus type 2 seropositive African women: a randomized, placebo-controlled trial.
Sex Transm Dis. 2012 Jan;39(1):21-4. doi: 10.1097/OLQ.0b013e31823b50c6.
2
Improvement in healing and reduction in HIV shedding with episodic acyclovir therapy as part of syndromic management among men: a randomized, controlled trial.
J Infect Dis. 2009 Oct 1;200(7):1039-49. doi: 10.1086/605647.
3
Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial.
J Infect Dis. 2009 Jul 15;200(2):216-26. doi: 10.1086/599991.
4
Health care seeking among men with genital ulcer disease in South Africa: correlates and relationship to human immunodeficiency virus-1 and herpes simplex virus type 2 detection and shedding.
Sex Transm Dis. 2011 Sep;38(9):865-70. doi: 10.1097/OLQ.0b013e31821d4ceb.
5
Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial.
J Infect Dis. 2010 Apr 15;201(8):1164-8. doi: 10.1086/651381.
6
Patterns of herpes simplex virus shedding over 1 month and the impact of acyclovir and HIV in HSV-2-seropositive women in Tanzania.
Sex Transm Infect. 2011 Aug;87(5):406-11. doi: 10.1136/sti.2010.048496. Epub 2011 Jun 8.
7
Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes.
AIDS. 2007 Jul 31;21(12):1569-78. doi: 10.1097/QAD.0b013e32825a69bd.
8
Acyclovir achieves a lower concentration in African HIV-seronegative, herpes simplex virus 2-seropositive women than in non-African populations.
Antimicrob Agents Chemother. 2012 May;56(5):2777-9. doi: 10.1128/AAC.06160-11. Epub 2012 Feb 13.
9
Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa.
AIDS. 2009 Feb 20;23(4):461-9. doi: 10.1097/QAD.0b013e32831db217.
10
Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
Mayo Clin Proc. 2006 Oct;81(10):1321-7. doi: 10.4065/81.10.1321.
引用本文的文献
1
20 years of herpes simplex virus type 2 (HSV-2) research in low-income and middle-income countries: systematic evaluation of progress made in addressing WHO priorities for research in HSV-2/HIV interactions, HSV-2 control and mathematical modelling.
BMJ Glob Health. 2024 Jul 4;9(7):e015167. doi: 10.1136/bmjgh-2024-015167.
2
Decreased monocyte activation with daily acyclovir use in HIV-1/HSV-2 coinfected women.
Sex Transm Infect. 2015 Nov;91(7):485-8. doi: 10.1136/sextrans-2014-051867. Epub 2015 Apr 22.
3
High frequency of transmitted HIV-1 Gag HLA class I-driven immune escape variants but minimal immune selection over the first year of clade C infection.
PLoS One. 2015 Mar 17;10(3):e0119886. doi: 10.1371/journal.pone.0119886. eCollection 2015.
4
Infectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventions.
Curr HIV Res. 2012 Apr;10(3):228-37. doi: 10.2174/157016212800618156.
本文引用的文献
1
Genital ulcer disease treatment policies and access to acyclovir in eight sub-Saharan African countries.
Sex Transm Dis. 2010 Aug;37(8):488-93. doi: 10.1097/OLQ.0b013e3181e212e5.
2
Impact of aciclovir on ulcer healing, lesional, genital and plasma HIV-1 RNA among patients with genital ulcer disease in Malawi.
Sex Transm Infect. 2010 Oct;86(5):345-52. doi: 10.1136/sti.2009.041814. Epub 2010 May 5.
3
Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial.
J Infect Dis. 2010 Apr 15;201(8):1164-8. doi: 10.1086/651381.
4
Improvement in healing and reduction in HIV shedding with episodic acyclovir therapy as part of syndromic management among men: a randomized, controlled trial.
J Infect Dis. 2009 Oct 1;200(7):1039-49. doi: 10.1086/605647.
5
Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition.
Nat Med. 2009 Aug;15(8):886-92. doi: 10.1038/nm.2006. Epub 2009 Aug 2.
6
Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial.
J Infect Dis. 2009 Jul 15;200(2):216-26. doi: 10.1086/599991.
7
Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial.
Lancet. 2008 Jun 21;371(9630):2109-19. doi: 10.1016/S0140-6736(08)60920-4.
8
One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
Sex Transm Dis. 2008 Apr;35(4):383-6. doi: 10.1097/OLQ.0b013e31815e4190.
9
Effect of herpes simplex suppression on incidence of HIV among women in Tanzania.
N Engl J Med. 2008 Apr 10;358(15):1560-71. doi: 10.1056/NEJMoa0800260. Epub 2008 Mar 12.
10
Sexually transmitted diseases treatment guidelines, 2006.
MMWR Recomm Rep. 2006 Aug 4;55(RR-11):1-94.
Zotero 插件